| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Dividendenbekanntmachungen (21.04.2026) | 3.486 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECCO GROUP AG ADR US0067542045 0,6463 USD 0,5482 EUR ADTRACTION GROUP AB SE0016833149 1,1 SEK 0,1022 EUR AIRBUS SE NL0000235190 - 3... ► Artikel lesen | |
| Di | JPMORGAN stuft Nestle auf 'Neutral' | 558 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Nestle auf "Neutral" mit einem Kursziel von 90 Franken belassen. Celine Pannuti analysierte in einer am Dienstag vorliegenden... ► Artikel lesen | |
| Di | RBC stuft Richemont auf 'Neutral' | 448 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Richemont auf "Sector Perform" mit einem Kursziel von 165 Franken belassen. Die März-Exportzahlen für Schweizer Uhren belegten insgesamt einen... ► Artikel lesen | |
| Di | Sika AG: SIKA ERWEITERT AKTIVITÄTEN IN ZENTRALASIEN MIT NEUER LÄNDERGESELLSCHAFT IN KIRGISISTAN | 430 | GlobeNewswire (Deutschland) | SIKA ERWEITERT AKTIVITÄTEN IN ZENTRALASIEN MIT NEUER LÄNDERGESELLSCHAFT IN KIRGISISTAN Sika stärkt die Position in Zentralasien mit der Gründung einer neuen Ländergesellschaft in Kirgisistan. Mit diesem... ► Artikel lesen | |
| Di | FDA Accepts Application for Genentech's Gazyva for the Treatment of the Most Common Form of Lupus | 407 | Business Wire | FDA ACCEPTS APPLICATION FOR GENENTECH'S GAZYVA FOR THE TREATMENT OF THE MOST COMMON FORM OF LUPUS Filing acceptance based on Phase III ALLEGORY data for Gazyva showing a significant reduction... ► Artikel lesen | |
| Di | F. Hoffmann-La Roche Ltd: Roche's ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD | 358 | GlobeNewswire (Europe) | Phase III METEOROID study met its primary endpoint in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)MOGAD is a rare autoimmune disease of the central nervous system... ► Artikel lesen | |
| 01:22 | F. Hoffmann-La Roche Ltd: Roche's fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS | 357 | GlobeNewswire (Europe) | Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib compared to teriflunomide in reducing relapses and brain lesions in relapsing multiple sclerosis... ► Artikel lesen | |
| Di | Commerzbank AG (London Branch) - Post Stabilisation Notice - Swiss Re Subordinated Finance Plc EUR750,mil Tier 2 Notes | 344 | PR Newswire | Commerzbank AG (London Branch) - Post Stabilisation Notice - Swiss Re Subordinated Finance Plc EUR750,mil Tier 2 Notes
PR Newswire
LONDON, United Kingdom, April 21
Post... ► Artikel lesen | |
| Di | Keurig Dr Pepper, Nestlé USA Expand Partnership For Starbucks K-Cup Pods | 308 | AFX News | WASHINGTON (dpa-AFX) - Keurig Dr Pepper Inc. (KDP) on Tuesday said it renewed and expanded its partnership with Nestlé USA to manufacture and distribute Starbucks K-Cup pods in the U.S. and... ► Artikel lesen | |
| Di | F. Hoffmann-La Roche Ltd: FDA accepts application for Roche's Gazyva/Gazyvaro for the treatment of the most common form of lupus | 300 | GlobeNewswire (Europe) | Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE)If approved... ► Artikel lesen | |
| Di | Genentech's Gazyva SBLA For Systemic Lupus Erythematosus Accepted By FDA; Decision Due Dec 2026 | 284 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a unit of Roche Holding AG (RHHBY), announced Tuesday that the US Food and Drug Administration (FDA) has accepted its supplemental Biologics License... ► Artikel lesen | |
| Di | KI-Duell 2026: Knowledge Atlas schließt laut UBS zu Anthropic auf | 275 | IT-Times | BEIJING, China (IT-Times) - UBS hat zum chinesischen KI-Startup Knowledge Atlas (Zhipu AI) einen Research-Bericht veröffentlicht und sieht für 2026 einen Wendepunkt in der Entwicklung des Unternehmens.... ► Artikel lesen | |
| Di | Amrize Ltd: Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting | 233 | EQS Group (EN) | Amrize Ltd
/ Key word(s): AGMEGM
Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting 21.04.2026 / 22:15 CET/CEST
CHICAGO/ZUG, Switzerland April 21, 2026... ► Artikel lesen | |
| Di | Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting | 228 | Business Wire | Amrize (AMRZ) shareholders approved all proposals at the company's first Annual General Meeting today.
Shareholders approved a special, one-time dividend for 2025 of $0.44 per share to be paid... ► Artikel lesen | |
| Di | Logitech International: Logitech Listed on SIX Swiss Exchange's New Sustainability Index of 25 Leading Companies | 227 | Business Wire | Listing among 25 companies reflects Logitech's strong overall ESG performance, driven by a commitment to sustainable product innovation, responsible business practices, and actively traded stocks... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| ZURICH INSURANCE GROUP | 614,80 | 32,53 | +5,29 % | 30,00 | 10.04.2026 | |
| SWISS RE | 143,75 | 6,83 | +4,75 % | 6,31 | 14.04.2026 | |
| PARTNERS GROUP | 1.029,50 | 45,71 | +4,44 % | 46,00 | 22.05.2026 | |
| KUEHNE & NAGEL | 207,50 | 8,98 | +4,33 % | 6,00 | 08.05.2026 | |
| HOLCIM | 78,00 | 3,37 | +4,32 % | 1,70 | 18.05.2026 | |
| NESTLE | 82,19 | 3,36 | +4,09 % | 3,10 | 20.04.2026 | |
| SWISSCOM | 718,50 | 28,41 | +3,95 % | 26,00 | 27.03.2026 | |
| SWISS LIFE | 1.025,00 | 38,09 | +3,72 % | 36,50 | 11.05.2026 | |
| NOVARTIS | 126,86 | 4,11 | +3,24 % | 3,70 | 10.03.2026 | |
| UBS | 36,500 | 0,93 | +2,55 % | 1,10 | 21.04.2026 |
| Aktien WKN | Akt. Kurs Vortag | +/- % | Zeit | ||
|---|---|---|---|---|---|
| ABB LTD 919730 Tradegate | 80,120 81,38 | -0,24 -0,30 % | 21.04. | ||
| ALCON AG A2PDXE Xetra | 67,420 68,12 | -0,70 -1,03 % | 21.04. | ||
| AMRIZE AG A414LY Tradegate | 48,740 49,440 | +0,050 +0,10 % | 21.04. | ||
| COMPAGNIE FINANCIERE RICHEMONT AG A1W5CV Tradegate | 169,850 172,80 | +1,10 +0,65 % | 21.04. | ||
| GEBERIT AG A0MQWG Tradegate | 589,000 594,60 | +3,20 +0,55 % | 21.04. | ||
| GIVAUDAN SA 938427 Tradegate | 3.100,000 3.187,00 | -6,00 -0,19 % | 21.04. | ||
| HOLCIM LTD 869898 Tradegate | 78,000 79,32 | +0,16 +0,21 % | 21.04. | ||
| KUEHNE & NAGEL INTERNATIONAL AG A0JLZL Tradegate | 207,500 204,90 | +1,70 +0,83 % | 21.04. | ||
| LOGITECH INTERNATIONAL SA A0J3YT Xetra | 84,380 84,88 | -0,50 -0,59 % | 21.04. | ||
| LONZA GROUP AG 928619 Tradegate | 555,800 575,20 | +2,60 +0,47 % | 21.04. |